Clinical Trial Update: Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS [Phase 3]

View source ↗

Summary

Phase 3 trial comparing NiCord (omidubicel) stem cell transplantation to standard umbilical cord blood in patients with hematologic malignancies, including vari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Leukemia
• Lymphoma
• Myelodysplastic Syndromes

Drugs mentioned

• NiCord (omidubicel)
• Umbilical Cord Blood

Snippet

Sponsor: Gamida Cell ltd | Conditions: Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL) | Phase 3 | Status: COMPLETED | Results posted: 2022-10-25